Biosynex SA (ALBIO) Stock Statistics & Valuation Metrics

Biosynex SA has a market cap or net worth of €10.59M. The enterprise value is ―.

Biosynex SA has 18,748,032 shares outstanding. The number of shares has decreased by -2.65% in one year.

Biosynex SA’s return on equity (ROE) is -0.54 and return on invested capital (ROIC) is -14.02%.

The current PE Ratio of Biosynex SA is ―. Biosynex SA’s PEG ratio is -0.03.

In the last 12 months, Biosynex SA had revenue of 101.20M and earned -43.30M in profits. Earnings per share was -3.32.

In the last 12 months, operating cash flow was -10.12M and capital expenditures -4.84M, giving a free cash flow of -14.96M billion.

Biosynex SA pays an annual dividend of €2, resulting in a dividend yield of ―

Biosynex SA upcoming earnings date is ―, ―.

Biosynex SA as a current ratio of 0.75, with Debt / Equity ratio of 77.51%

In the past 12 months, Biosynex SA has paid 1.40M in taxes.

Biosynex SA EV to EBITDA ratio is -3.29, with an EV/FCF ratio of -5.10.

Biosynex SA has €9.69M in cash and marketable securities with €62.46M in debt, giving a net cash position of -€52.77M billion.

Gross margin is -19.76%, with operating margin of -20.85%, and net profit margin of -42.79%.

The average price target for Biosynex SA is ―, which is 11.43% higher than the current price. The consensus rating is ―